Skip to Main Content

Paper Details

A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy.
Breast Cancer Res Treat
5
2021
ABC, HER2, HR, PR, aromatase, fulvestrant, hormone receptor, hormone receptor-positive advanced breast cancer, hormone receptor-positive, human epidermal, human, human epidermal growth factor receptor 2, patient, patients, women
Author NameAffiliation
Mei-Yin C PolleyUniversity of Chicago
Matthew P Goetz
Matthew P GoetzMayo Clinic
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Matthew J EllisDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine
  • 1 - 6

Datasets

Release 1.2